Diabetes News You Can Use

Being overweight, obese increases mortality risks, study says

Research in the Annals of Internal Medicine found overall mortality risks increased by 10% for people who were overweight, 34% for those who were obese and 98% for the morbidly obese. The study, which considered patient data over 12 years, contradicts the “obesity paradox” theory that being overweight may have health or survival benefits for some people, researchers said.

HealthDay News (4/3)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Study: Poor blood glucose control seen among night shift workers with diabetes

A study presented at the Endocrine Society meeting showed that night shift workers with type 2 diabetes have poorer blood glucose control, higher body mass index, less sleep and more calorie consumption than those who work in the daytime or were unemployed. Thai researchers used a cohort of 260 people and found that the average A1C among those who worked night shifts was 66.1 mmol/mol, 59.6 mmol/mol among those who worked during the day and 58.5 mmol/mol among those who did not have a job.

Diabetes.co.uk (U.K.) (4/4)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Study: Improved outcomes seen with insulin pump therapy use in adolescents

Adolescent type 2 diabetes patients who used an insulin pump therapy for three months reduced their A1C levels by 1.3% and their average blood glucose from 205±91 mg/dL to 161±70 mg/dL, according to a study presented at ENDO 2017: the 99th Annual Meeting & Expo. Researchers evaluated five female patients with poor glycemic control and found that the two who continued using insulin pumps had a 30% drop in insulin requirements and improved quality of life parameters.

ClinicalAdvisor.com (4/3)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Study: Newer oral glucose-lowering drugs have risk reduction benefits

A study in Diabetes, Obesity & Metabolism showed that type 2 diabetes patients treated with SGLT2 inhibitor dapagliflozin had a 56% lower risk for all-cause mortality and a 49% reduced risk for fatal and nonfatal cardiovascular disease, compared with those on insulin. Swedish researchers evaluated more than 20,000 adults with type 2 diabetes and found that the risk for severe hypoglycemia was 69% lower among those on dipeptidyl peptidase-4 inhibitors than those on insulin, while no significant risk reduction was seen with dapagliflozin.

Diabetes.co.uk (U.K.) (3/30) 

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

11 cancers associated with obesity, study finds

A study in The BMJ found an association between obesity and 11 cancers, including multiple myeloma, colon cancer, biliary tract system cancer, breast cancer and kidney cancer. UK researchers evaluated 95 meta-analyses and found that the increase in cancer risk for every 5-kg/m2 increase in body mass index ranged from 9% for rectal cancer in male patients to 56% for biliary tract system cancer.

Medscape (free registration) (2/28)

News provided by DiabetesPro SmartBrief in conjunction with the American Diabetes Association.

Upcoming Events

Diabetes and Metabolism Seminar Series

2017 ANNUAL SYMPOSIUM - Role of HDL and Triglycerides in Diabetes and Cardiovascular Disease (Diabetes and Metabolism Seminar Series)

05-11-2017 - 8:00 am
UW Center for Urban Horticulture
3501 NE 41st Street
Seattle, WA 98195

2017 Annual Symposium
Role of HDL and Triglycerides in Diabetes and Cardiovascular Disease

Location: UW Center for Urban Horticulture
Map

Registration is required. Please click the following link to register online by April 28th:
2017 Annual Symposium

Download Flyer

Other Events

Veterans Affairs RTC

Shelly Ericksoon (VA RTC)

05-01-2017 - 3:30 pm
VA Puget Sound Health Care System
1660 S. Columbian Way
Seattle, WA 98108

What the HDL mediates Serum Amyloid A interactions with the Blood-brain Barrier?

Mentor: Banks

Location: Bldg. 1, Room 227

Benaroya Research Institute Translational Meeting

Asa Davis (Benaroya Research Institute Translational Meeting)

05-03-2017 - 12:30 pm
Benaroya Research Institute at Virginia Mason
1201 9th Avenue
Seattle, WA 98101-2795

 

Location: 4North

South Lake Union RTC

Hy-Seung Jung (SLU RTC)

05-03-2017 - 3:00 pm
UW SLU
850 Republican St
Seattle, WA 98109

Mentor (group): Bornfeldt

Location: E130